Medicare Enrolled
Dr. James Charles, M.D.
Optician · Bayonne, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Charles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Charles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Charles
Dr. James Charles is an optician specialist in Bayonne, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Charles performed 5,956 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Charles received a total of $151,454 from 68 pharmaceutical and/or device companies across 1405 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Charles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in NJ
$151,454 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,956
Medicare services
Top 11% in NJ for optician
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,502 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
145 | $111 | $201 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
76 | $71 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $78 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $157 | $225 |
| New patient office visit, complex (60-74 min) | 45 | $188 | $351 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $143 | $287 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
24 | $82 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $13 | $61 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
17 | $90 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$151,454
Total received (2018-2024)
Avg $21,636/year across 7 years
Top 2% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,405
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,528
2023
$11,292
2022
$26,573
2021
$43,942
2020
$13,704
2019
$21,539
2018
$26,877
Payments by company (2024)
ABBVIE INC.
$5,049
PFIZER INC.
$466
Lundbeck LLC
$315
Teva Pharmaceuticals USA, Inc.
$305
Amneal Pharmaceuticals LLC
$257
EMD Serono, Inc.
$252
Axsome Therapeutics, Inc.
$158
Kyowa Kirin, Inc.
$112
Neurocrine Biosciences, Inc.
$83
Celgene Corporation
$81
Lilly USA, LLC
$67
SK Life Science, Inc.
$66
ARGENX US, INC.
$60
UCB, Inc.
$59
Biogen, Inc.
$57
Genentech USA, Inc.
$33
Alexion Pharmaceuticals, Inc.
$17
ACADIA Pharmaceuticals Inc
$16
Amgen Inc.
$16
SCILEX PHARMACEUTICALS INC.
$16
Harmony Biosciences Llc
$15
Novartis Pharmaceuticals Corporation
$15
Grifols USA, LLC
$14
Top 3 companies account for 77.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$45,860
Biohaven Pharmaceuticals, Inc.
$20,426
Teva Pharmaceuticals USA, Inc.
$15,765
AbbVie Inc.
$12,714
ABBVIE INC.
$12,043
Allergan, Inc.
$9,218
Biohaven Pharmaceutical Holding Company Ltd.
$9,016
Supernus Pharmaceuticals, Inc.
$8,238
Assertio Therapeutics, Inc.
$6,562
Lundbeck LLC
$1,964
EMD Serono, Inc.
$898
Biogen, Inc.
$841
Amneal Pharmaceuticals LLC
$805
PFIZER INC.
$664
Lilly USA, LLC
$500
UCB, Inc.
$491
Allergan Inc.
$454
US WorldMeds, LLC
$381
Kyowa Kirin, Inc.
$311
Axsome Therapeutics, Inc.
$301
SK Life Science, Inc.
$271
Eisai Inc.
$256
Novartis Pharmaceuticals Corporation
$226
Genentech USA, Inc.
$222
Acorda Therapeutics, Inc
$212
JAZZ PHARMACEUTICALS INC.
$211
NOVARTIS PHARMACEUTICALS CORPORATION
$203
ACADIA Pharmaceuticals Inc
$180
Celgene Corporation
$167
MDD US Operations, LLC
$153
Alexion Pharmaceuticals, Inc.
$144
BANNER LIFE SCIENCES, LLC
$125
ARGENX US, INC.
$124
Neurocrine Biosciences, Inc.
$110
UPSHER-SMITH LABORATORIES LLC
$103
Impax Laboratories, Inc.
$96
EISAI INC.
$93
Merck Sharp & Dohme LLC
$71
Upsher-Smith Laboratories LLC
$70
Avanir Pharmaceuticals, Inc.
$68
Currax Pharmaceuticals LLC
$68
Pernix Therapeutics Holdings, Inc.
$67
Janssen Pharmaceuticals, Inc
$56
Adamas Pharmaceuticals, Inc.
$54
Bausch Health US, LLC
$53
Grifols USA, LLC
$53
GE HealthCare
$50
Mallinckrodt LLC
$49
Collegium Pharmaceutical, Inc.
$43
Scilex Pharmaceuticals Inc.
$40
E.R. Squibb & Sons, L.L.C.
$39
Mallinckrodt Enterprises LLC
$37
Mallinckrodt Hospital Products Inc.
$29
Otsuka America Pharmaceutical, Inc.
$28
Avion Pharmaceuticals
$27
ASSERTIO THERAPEUTICS, Inc.
$26
TG THERAPEUTICS, INC.
$22
BOSTON SCIENTIFIC CORPORATION
$19
SCILEX PHARMACEUTICALS INC.
$16
Harmony Biosciences Llc
$15
Vertical Pharmaceuticals, LLC
$15
Almatica Pharma LLC
$15
Harmony Biosciences LLC
$15
TerSera Therapeutics LLC
$14
Merck Sharp & Dohme Corporation
$12
Neurelis, Inc.
$12
Egalet US Inc
$11
Sumitomo Pharma America, Inc.
$10
Top 3 companies account for 54.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · Cenobamate · DUOPA · Dhivy · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ERGOMAR · Enspryng · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LINZESS · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · QULIPTA · REXULTI · RYTARY · SILENOR · SOLIRIS · SPRIX · SUNOSI · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WELLBUTRIN XL · Wakix · XADAGO · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
13,917
County median income
$90,032
Nearest hospital to ZIP centroid (approximate)
CAREPOINT HEALTH - BAYONNE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Charles is a mixed practice specialist, with above-average Medicare volume (top 11% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Charles experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Charles performed 5,502 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Charles receive payments from pharmaceutical companies?
Yes. Dr. Charles received a total of $151,454 from 68 companies across 1,405 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Charles's costs compare to other opticians in Bayonne?
Dr. Charles's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Charles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bayonne
Browse opticians in Bayonne ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology